ICAM1 and neoplasm: Furthermore, tumor-derived exosomal CMTM4 induces M2 macrophage polarization and immune suppression via the NF-B pathway and ICAM1 upregulation, promoting metastasis and attenuating anti-PD-1 sensitivity; its inhibition with Eltrombopag can enhance immunotherapy (68).